STX — Shield Therapeutics Share News
0.000.00%
Last trade - 00:00- £24.48m
- £36.35m
- £13.09m
REG - Shield Therapeutics - $5.7m Milestone Monetization Agreement with AOP
AnnouncementREG - Shield Therapeutics - Results of 2024 Annual General Meeting
AnnouncementREG - Shield Therapeutics - New Drug Application for Accrufer® in South Korea
AnnouncementREG - Shield Therapeutics - Audited results for the year ended 31 Dec 2023
AnnouncementREG - Shield Therapeutics - Business Update for Q1 2024
AnnouncementREG - Shield Therapeutics - Notice of Results
AnnouncementREG - Shield Therapeutics - Unaudited Full Year Trading Update
AnnouncementREG - Shield Therapeutics - Appointment of new Chief Financial Officer
AnnouncementREG - Shield Therapeutics - Q3 2023 U.S. Commercial Highlights
AnnouncementREG - Shield Therapeutics - PDMR Transaction Notification
AnnouncementRCS - Shield Therapeutics - Abstract to be presented at Healthcare Conference
AnnouncementREG - Shield Therapeutics - Chief Financial Officer Transition
AnnouncementREG - Shield Therapeutics - Result of REX Retail Offer
AnnouncementREG - Shield Therapeutics - Completion of SWK Financing
AnnouncementREG - Shield Therapeutics - Block listing Interim Return
AnnouncementREG - Cavendish Financial - AGM Trading Statement
AnnouncementREG - Shield Therapeutics - Successful completion of US$6.1m Equity Fundraise
AnnouncementREG - Shield Therapeutics - $20m secured debt facility &proposed equity raise
AnnouncementREG - Shield Therapeutics - REX Retail Offer
Announcement